04:52 PM EDT, 07/30/2025 (MT Newswires) -- Bausch Health ( BHC ) was last seen up 1.9% in New York after-hours trade on Wednesday after its second-quarter adjusted profit and revenue both rose.

Consolidated adjusted net income attributable to Bausch Health ( BHC ), which excludes most one-time items, rose to US$335 million from US$328 million in the year-prior quarter. The increase was primarily due to higher revenue.

Revenue rose 5% to US$2.53 billion, topping the consensus analyst forecast of US$2.47 billion, according to FactSet.

"In the second quarter, we achieved our ninth consecutive quarter of year-over-year growth in Revenue and Adjusted EBITDA for Bausch Health ( BHC ), excluding Bausch + Lomb ( BLCO ). This consistent performance highlights our operational excellence and the strength of our diverse portfolio across therapeutic areas and geographies. As we look toward the second half of 2025, we remain focused on executing against our strategic priorities to drive continued growth and unlock long-term value for our shareholders," said Thomas Appio, chief executive officer.

Bausch Health ( BHC ) shares were last seen up US$0.12 to US$6.51 after hours. They closed down $0.56 to $8.85 on the Toronto Stock Exchange.